Related Experiment Video
Updated: Jun 28, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
A benefit risk approach in cutoff determination for diagnostic tests
Jeng Mah1, Robert Magari2, Karen Kw Lo2
1Department of Biostatistics and Data Management, Beckman Coulter, Inc. Chaska, MN, USA.
Determining the optimal cutoff for diagnostic tests is crucial. A proposed net benefit-risk (BR) equation helps optimize test performance by considering disease prevalence and diagnostic accuracy, as demonstrated with a SARS-CoV-2 test.
Area of Science:
- Biomedical engineering
- Medical diagnostics
- Health informatics
Background:
- Accurate diagnostic testing relies on establishing an appropriate cutoff point to distinguish between negative and positive results.
- Clinical decisions and patient outcomes are directly influenced by the accuracy of diagnostic test results.
- Benefit-Risk (BR) analysis offers a framework for optimizing these cutoff points by quantifying potential benefits and risks.
Purpose of the Study:
- To propose a quantitative method for determining the optimal cutoff point for diagnostic tests.
- To introduce a net benefit-risk (linear BR) equation for optimizing diagnostic test performance.
- To provide a framework for comparing diagnostic tests based on their benefit-risk profiles.
Main Methods:
- Development of a net benefit-risk (linear BR) equation.
- Scaling benefit and risk components in units of risk from untreated disease.
- Utilizing diagnostic parameters, disease prevalence, and accuracy metrics within the BR equation.
- Application of the method to a biosensor rapid antigen test for SARS-CoV-2.
Main Results:
- The proposed net BR equation provides a function to determine the optimal cutoff point for diagnostic tests.
- The method allows for the comparison of different diagnostic tests based on their overall benefit and risk.
- The framework is illustrated effectively using a real-world example of a SARS-CoV-2 rapid antigen test.
Conclusions:
- The net benefit-risk equation offers a robust approach to optimizing diagnostic test cutoff points.
- This quantitative method enhances clinical decision-making by balancing the benefits of accurate diagnosis against the risks of errors.
- The framework is broadly applicable to various diagnostic tests, improving their clinical utility and design.
More Related Videos
09:00Author Spotlight: Validation of SICOLE-R for Assessing Cognitive and Reading Skills in Spanish-Speaking Children and Its Role in Personalized Education
Published on: August 16, 2024
12:18A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Related Concept Videos
Receiver Operating Characteristic Plot
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Kaplan-Meier Approach
Critical Region, Critical Values and Significance Level
In hypothesis testing, a sample statistic is converted to a test statistic using z, t, or chi-square distribution. A critical region is an area under the curve in probability distributions demarcated by the critical value. When the test statistic falls in this region, it suggests that the null hypothesis must be rejected. As this region contains all those values of the...